Julie B. Andrews's most recent trade in RxSight Inc was a trade of 10,752 Common Stock done . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RxSight Inc | Julie B. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 10,752 | 41,039 | - | - | Common Stock | |
| Orthofix Medical Inc | Julie B. Andrews | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 82,070 | 82,070 | - | - | Employee Stock Option (Right to Buy) | |
| Orthofix Medical Inc | Julie B. Andrews | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 34,600 | 62,912 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Julie B. Andrews | CFO | Sale of securities on an exchange or to another person at price $ 17.89 per share. | 16 Jan 2025 | 4,655 | 28,312 (0%) | 0% | 17.9 | 83,278 | Common Stock |
| RxSight Inc | Julie B. Andrews | Director | Sale of securities on an exchange or to another person at price $ 57.84 per share. | 14 Jun 2024 | 11,940 | 33,972 | - | 57.8 | 690,608 | Common Stock |
| RxSight Inc | Julie B. Andrews | Director | Sale of securities on an exchange or to another person at price $ 58.53 per share. | 14 Jun 2024 | 3,685 | 30,287 | - | 58.5 | 215,680 | Common Stock |
| RxSight Inc | Julie B. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 2,554 | 45,912 | - | - | Common Stock | |
| Orthofix Medical Inc | Julie B. Andrews | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 76,878 | 76,878 | - | - | Employee Stock Option (right to buy) | |
| Orthofix Medical Inc | B. Julie Andrews | CFO | Grant, award, or other acquisition of securities at price $ 13.65 per share. | 15 Jan 2024 | 32,967 | 32,967 (0%) | 0% | 13.7 | 450,000 | Common Stock |
| RxSight Inc | Julie B. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,731 | 43,358 | - | 0 | Common Stock | |
| RxSight Inc | Julie B. Andrews | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 03 Aug 2021 | 15,625 | 29,003 | - | 16 | 250,000 | Common Stock |
| RxSight Inc | Julie B. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 7,645 | 13,378 | - | 0 | Common Stock | |
| RxSight Inc | Julie B. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 5,733 | 5,733 | - | 0 | Common Stock |